vs
Side-by-side financial comparison of HANMI FINANCIAL CORP (HAFC) and STEM, INC. (STEM). Click either name above to swap in a different company.
HANMI FINANCIAL CORP is the larger business by last-quarter revenue ($71.2M vs $47.1M, roughly 1.5× STEM, INC.). HANMI FINANCIAL CORP runs the higher net margin — 29.8% vs -33.9%, a 63.7% gap on every dollar of revenue. On growth, HANMI FINANCIAL CORP posted the faster year-over-year revenue change (17.1% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 10.4%).
Hanmi Bank Corporation is a community bank headquartered in Los Angeles, California, with 35 branches and eight loan production offices in California, Texas, Illinois, New York, New Jersey and Virginia.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
HAFC vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $71.2M | $47.1M |
| Net Profit | $21.2M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | 29.8% | -17.7% |
| Net Margin | 29.8% | -33.9% |
| Revenue YoY | 17.1% | -15.6% |
| Net Profit YoY | 20.0% | 68.8% |
| EPS (diluted) | $0.70 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $71.2M | $47.1M | ||
| Q3 25 | $71.0M | $38.2M | ||
| Q2 25 | $65.2M | $38.4M | ||
| Q1 25 | $62.8M | $32.5M | ||
| Q4 24 | $60.8M | $55.8M | ||
| Q3 24 | $58.5M | $29.3M | ||
| Q2 24 | $56.7M | $34.0M | ||
| Q1 24 | $58.4M | $25.5M |
| Q4 25 | $21.2M | $-16.0M | ||
| Q3 25 | $22.1M | $-23.8M | ||
| Q2 25 | $15.1M | $202.5M | ||
| Q1 25 | $17.7M | $-25.0M | ||
| Q4 24 | $17.7M | $-51.1M | ||
| Q3 24 | $14.9M | $-148.3M | ||
| Q2 24 | $14.5M | $-582.3M | ||
| Q1 24 | $15.2M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | 29.8% | -17.7% | ||
| Q3 25 | 31.1% | -33.6% | ||
| Q2 25 | 23.2% | -34.8% | ||
| Q1 25 | 28.1% | -65.0% | ||
| Q4 24 | 29.1% | -84.4% | ||
| Q3 24 | 25.5% | -493.2% | ||
| Q2 24 | 25.5% | -1705.5% | ||
| Q1 24 | 26.0% | -267.0% |
| Q4 25 | 29.8% | -33.9% | ||
| Q3 25 | 31.1% | -62.2% | ||
| Q2 25 | 23.2% | 527.8% | ||
| Q1 25 | 28.1% | -76.9% | ||
| Q4 24 | 29.1% | -91.6% | ||
| Q3 24 | 25.5% | -506.3% | ||
| Q2 24 | 25.5% | -1712.6% | ||
| Q1 24 | 26.0% | -283.9% |
| Q4 25 | $0.70 | $-4.40 | ||
| Q3 25 | $0.73 | $-2.84 | ||
| Q2 25 | $0.50 | $-1.79 | ||
| Q1 25 | $0.58 | $-0.15 | ||
| Q4 24 | $0.58 | $-15.29 | ||
| Q3 24 | $0.49 | $-18.24 | ||
| Q2 24 | $0.48 | $-71.81 | ||
| Q1 24 | $0.50 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $796.4M | $-249.4M |
| Total Assets | $7.9B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.9M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | — | $40.8M | ||
| Q1 25 | — | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M | ||
| Q1 24 | — | $112.8M |
| Q4 25 | $796.4M | $-249.4M | ||
| Q3 25 | $779.5M | $-235.7M | ||
| Q2 25 | $762.8M | $-214.1M | ||
| Q1 25 | $751.5M | $-417.5M | ||
| Q4 24 | $732.2M | $-398.4M | ||
| Q3 24 | $736.7M | $-344.1M | ||
| Q2 24 | $707.1M | $-203.2M | ||
| Q1 24 | $703.1M | $371.6M |
| Q4 25 | $7.9B | $308.9M | ||
| Q3 25 | $7.9B | $362.6M | ||
| Q2 25 | $7.9B | $379.2M | ||
| Q1 25 | $7.7B | $405.1M | ||
| Q4 24 | $7.7B | $437.4M | ||
| Q3 24 | $7.7B | $537.8M | ||
| Q2 24 | $7.6B | $691.5M | ||
| Q1 24 | $7.5B | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $206.0M | $8.2M |
| Free Cash FlowOCF − Capex | $203.7M | — |
| FCF MarginFCF / Revenue | 286.2% | — |
| Capex IntensityCapex / Revenue | 3.2% | — |
| Cash ConversionOCF / Net Profit | 9.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $356.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $206.0M | $8.2M | ||
| Q3 25 | $146.9M | $11.4M | ||
| Q2 25 | $-19.0M | $-21.3M | ||
| Q1 25 | $25.8M | $8.5M | ||
| Q4 24 | $52.6M | $-14.7M | ||
| Q3 24 | $6.7M | $-9.4M | ||
| Q2 24 | $2.1M | $-11.9M | ||
| Q1 24 | $30.0M | $-621.0K |
| Q4 25 | $203.7M | — | ||
| Q3 25 | $146.4M | — | ||
| Q2 25 | $-19.6M | — | ||
| Q1 25 | $25.6M | — | ||
| Q4 24 | $49.9M | — | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $29.2M | — |
| Q4 25 | 286.2% | — | ||
| Q3 25 | 206.3% | — | ||
| Q2 25 | -30.0% | — | ||
| Q1 25 | 40.7% | — | ||
| Q4 24 | 82.1% | — | ||
| Q3 24 | 11.1% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 50.0% | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 9.70× | — | ||
| Q3 25 | 6.66× | — | ||
| Q2 25 | -1.26× | -0.11× | ||
| Q1 25 | 1.46× | — | ||
| Q4 24 | 2.97× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 1.98× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
